{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:04:06Z","timestamp":1785380646387,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clinthera.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T23:15:04Z","timestamp":1320448504000},"page":"1643-1658","source":"Crossref","is-referenced-by-count":38,"title":["Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct00422123","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Andrew J.","family":"Cutler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Datto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Nordenhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Minkwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Darko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.10.002_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4088\/JCP.v64n0111","article-title":"Screening for bipolar disorder in the community","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)","year":"2000"},{"key":"10.1016\/j.clinthera.2011.10.002_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11920-003-0077-2","article-title":"Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder","volume":"5","author":"Judd","year":"2003","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.clinthera.2011.10.002_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1176\/appi.ajp.162.7.1273","article-title":"Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients","volume":"162","author":"Kupka","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000228249","article-title":"Functioning and disability in bipolar disorder: an extensive review","volume":"78","author":"Sanchez-Moreno","year":"2009","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.clinthera.2011.10.002_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1399-5618.2007.00365.x","article-title":"Prevalence and correlates of burden among caregivers of patients with bipolar disorder enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder","volume":"9","author":"Perlick","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clinthera.2011.10.002_bib8","doi-asserted-by":"crossref","first-page":"e05","DOI":"10.4088\/JCP.0208e05","article-title":"Interventions for acute mood episodes in patients with bipolar disorder","volume":"69","author":"Garlow","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2011.10.002_bib9","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.clinthera.2011.10.002_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition\u2014recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.10.002_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","article-title":"Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania","volume":"24","author":"Yatham","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.10.002_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1185\/030079905X46340","article-title":"Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies","volume":"21","author":"Vieta","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2011.10.002_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania\u2014a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.clinthera.2011.10.002_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.10.002_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","article-title":"A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)","volume":"71","author":"Young","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","article-title":"A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)","volume":"71","author":"McElroy","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pnpbp.2008.09.026","article-title":"Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release","volume":"33","author":"Figueroa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.pra.0000388626.98662.a0","article-title":"Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines","volume":"16","author":"Velligan","year":"2010","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.clinthera.2011.10.002_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2011.10.002_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2011.10.002_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clinthera.2011.10.002_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.clinthera.2011.10.002_bib29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1176\/appi.ajp.164.7.1035","article-title":"Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA's Pediatric Suicidal Risk Analysis of Antidepressants","volume":"164","author":"Posner","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881108099418","article-title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study","volume":"24","author":"Vieta","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.10.002_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2011.10.002_bib33","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1001\/jama.255.22.3138","article-title":"Differential outcome of pure manic, mixed\/cycling, and pure depressive episodes in patients with bipolar illness","volume":"255","author":"Keller","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.10.002_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania","volume":"54","author":"Swann","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib35","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4088\/JCP.08m04045","article-title":"Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania","volume":"70","author":"Keck","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy","volume":"59","author":"Tohen","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1176\/appi.ajp.158.8.1324","article-title":"Does the manic\/mixed episode distinction in bipolar disorder patients run true over time?","volume":"158","author":"Woods","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib38","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.eurpsy.2004.04.019","article-title":"Dimensions of mania: differences between mixed and pure episodes","volume":"19","author":"Gonzalez-Pinto","year":"2004","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.biopsych.2004.09.022","article-title":"Mood state at study entry as predictor of the polarity of relapse in bipolar disorder","volume":"56","author":"Calabrese","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib42","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania: double-blind, placebo-controlled study","volume":"187","author":"Khanna","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2011.10.002_bib45","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T21:50:19Z","timestamp":1543441819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811006734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0149291811006734"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.10.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}